| Date | Presenter | Title |
| March 17, 2023 | Tanvi Bhatt, PhD | Evidence-based balance training: Slips, Trips and Beyond |
| February, 17, 2023 | Emmett Whitaker, MD | Cerebrovascular Function, Disease, and the Quest for the Ideal Anesthetic in Neonates and Infants |
| January 20, 2023 | Nicholas Klug, PhD | Emerging contractile and electrical properties of CNS capillary pericytes |
| December 16,2022 | Matthew Caporizzo, PhD | The Molecular Underpinnings of Diastolic Dysfunction |
| October 21, 2022 | Manuel Navedo PhD University of California, Davis | Spatiotemporal control of vascular CaV1.2 channels by a single amino acid |
| September 9, 2022 | Eliza Miller, MD, MD Columbia University, NY | Neuro-Obstetics: Partnering to Prevent Maternal Neurological Morbidity and Mortality |
| May 20, 2022 | Costantino Iadecola, MD | Neurovascular Pathology of Amyloid-Beta and Tau: From Bench to Bedside |
| March 18,2022 | Iris Jaffe, MD, PhD | Vascular Mineralocorticoid Receptors in Cardiovascular Disease |
| February 18,2022 | Catherine Lang, PT, PhD, FAPTA | Translation of in-clinic gains to gains in daily life after stroke |
| January 21, 2022 | Neil Zakai, MD, MSc & Peter Durda, PhD | How can the Study Design and Molecular Epidemiology Core help your research? |
| December 17, 2021 | Marilyn Cipolla, PhD | Role of the blood-brain barrier and microvascular function in brain injury during preeclampsia and eclampsia |
| November 12, 2021 | Mitchell S. V. Elkind, MD, MS, FAAN, FAHA | Infection as a Stroke Risk Factor, Trigger, and Determinant of Outcome |
| October 15, 2021 | Yangguang Ou, PhD | Developing Adaptive Chemical Sensing Technologies for Understanding the Etiology of Brain and Cardiovascular Disorders |
| September 17, 2021 | Neil Zakai MD, Mary Cushman MD, MSc & Andrew Wilcock PhD | Mini Research COVID Slam |
| June 18, 2021 | Teresa Sanchez, PhD, Cornell | Neurovascular Signaling Pathways in Health and Disease: Mechanistic Insights and Therapeutic Opportunities |
| May 21, 2021 | David Punihaole, PhD | Developing new imaging tools to understand the crosstalk between Alzheimer’s Disease and Cerebral Amyloid Angiopathy. |
| April 16, 2021 | Masayo Koide, PhD | Hyperaldosteronemia: a hidden risk for cognitive impairment? |
| March 19, 2021 | Denise Peters, PT, DPT, PhD | Predicting recovery potential and optimizing outcomes post-stroke |
| February 19, 2021 | Katharine Cheung, MD, PhD | Kidney-brain axis: the epidemiology of cognitive impairment in kidney disease |
| January 6, 2021 | Marilyn Cipolla, PhD | How to prepare your RO1: my approach |
| December 20, 2020 | Mary Cushman, MD, MSc | Thrombosis and organ failure in COVID-19: mechanisms and therapy implications |
| November 20, 2020 | Osama Harraz, PhD | PIP2: The maestro of cerebral blood flow symphony |